Ifm Investors Pty LTD Legend Biotech Corp Transaction History

Ifm Investors Pty LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	BUY	$55.06 - $69.99 $204,382 - $259,802	3,712 New	3,712 $208,000
Q2 2023 Jul 27, 2023	SELL	$46.28 - $75.01 $211,545 - $342,870	-4,571 Reduced 55.19%	3,712 $256,000
Q1 2023 May 11, 2023	BUY	$43.42 - $57.37 $28,526 - $37,692	657 Added 8.62%	8,283 $399,000
Q4 2022 Feb 14, 2023	BUY	$38.8 - $55.46 $295,888 - $422,937	7,626 New	7,626 $380,000

212

77.9M

412K

387K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $6.73B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Ifm Investors Pty LTD, based on Form 13F filings with the SEC.

Stay updated on Ifm Investors Pty LTD with notifications on news.